Brief: Medigene H1 total revenue at EUR 4.9 mln
Aug 3 (Reuters) - MEDIGENE AG MDG1k.DE
* H1 REVENUE FROM CORE BUSINESS IMMUNOTHERAPIES (BLUEBIRD
BIO PARTNERSHIP) AMOUNTS TO EUR2,252 K (6M 2016: EUR0 K)
* H1 TOTAL REVENUE OF EUR4,915 K (6M 2016: EUR5,470 K)
* CONFIRMATION OF FINANCIAL GUIDANCE 2017
Source text for Eikon: ID:nPexZT1q0a
Further company coverage: MDG1k.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million